Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Determination of alternate splicing events using the Affymetrix Exon 1.0 ST arrays.

Subbaram S, Kuentzel M, Frank D, Dipersio CM, Chittur SV.

Methods Mol Biol. 2010;632:63-72. doi: 10.1007/978-1-60761-663-4_4.

2.

Implementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis.

Whistler T, Chiang CF, Lonergan W, Hollier M, Unger ER.

BMC Genomics. 2010 Sep 14;11:496. doi: 10.1186/1471-2164-11-496.

3.

Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation.

Ha KCh, Coulombe-Huntington J, Majewski J.

BMC Genomics. 2009 Nov 12;10:519. doi: 10.1186/1471-2164-10-519.

4.

A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.

Raghavachari N, Barb J, Yang Y, Liu P, Woodhouse K, Levy D, O'Donnell CJ, Munson PJ, Kato GJ.

BMC Med Genomics. 2012 Jun 29;5:28. doi: 10.1186/1755-8794-5-28.

5.

A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data.

Fan W, Khalid N, Hallahan AR, Olson JM, Zhao LP.

Theor Biol Med Model. 2006 Apr 7;3:19.

6.

Gene Array Analyzer: alternative usage of gene arrays to study alternative splicing events.

Gellert P, Teranishi M, Jenniches K, De Gaspari P, John D, Kreymborg Kg, Braun T, Uchida S.

Nucleic Acids Res. 2012 Mar;40(6):2414-25. doi: 10.1093/nar/gkr1110. Epub 2011 Nov 28.

7.

A cross-platform comparison of genome-wide expression changes of laser microdissected lung tissue of C-Raf transgenic mice using 3'IVT and exon array.

Londhe KB, Borlak J.

PLoS One. 2012;7(7):e40778. doi: 10.1371/journal.pone.0040778. Epub 2012 Jul 16. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/57bb672d-dd2f-4754-90ca-8575c1fd8903.

8.

Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.

Bemmo A, Dias C, Rose AA, Russo C, Siegel P, Majewski J.

PLoS One. 2010 Aug 6;5(8):e11981. doi: 10.1371/journal.pone.0011981.

9.

Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays.

Kechris K, Yang YH, Yeh RF.

BMC Genomics. 2008 Nov 20;9:551. doi: 10.1186/1471-2164-9-551.

10.

Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing.

Castle J, Garrett-Engele P, Armour CD, Duenwald SJ, Loerch PM, Meyer MR, Schadt EE, Stoughton R, Parrish ML, Shoemaker DD, Johnson JM.

Genome Biol. 2003;4(10):R66. Epub 2003 Sep 19.

11.

Identification and expression of deoxyribonuclease (DNase) I alternative transcripts in the rat.

Basnakian AG, Singh AB, Shah SV.

Gene. 2002 May 1;289(1-2):87-96.

PMID:
12036587
12.

Gene expression and isoform variation analysis using Affymetrix Exon Arrays.

Bemmo A, Benovoy D, Kwan T, Gaffney DJ, Jensen RV, Majewski J.

BMC Genomics. 2008 Nov 7;9:529. doi: 10.1186/1471-2164-9-529. Erratum in: BMC Genomics. 2009 Mar 23;10. doi: 10.1186/1471-2164-10-121.

13.

Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.

Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, Beck S, Millevoi S, Tazi J, Lidereau R, Vagner S, Auboeuf D.

Cancer Res. 2010 Feb 1;70(3):896-905. doi: 10.1158/0008-5472.CAN-09-2703. Epub 2010 Jan 26.

14.

A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.

Yoshida R, Numata K, Imoto S, Nagasaki M, Doi A, Ueno K, Miyano S.

Genome Inform. 2006;17(1):88-99.

PMID:
17503359
15.

A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling.

Bradford JR, Hey Y, Yates T, Li Y, Pepper SD, Miller CJ.

BMC Genomics. 2010 May 5;11:282. doi: 10.1186/1471-2164-11-282.

16.

Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.

Langer W, Sohler F, Leder G, Beckmann G, Seidel H, Gröne J, Hummel M, Sommer A.

BMC Genomics. 2010 Nov 30;11:676. doi: 10.1186/1471-2164-11-676.

18.

Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.

Renshaw J, Orr RM, Walton MI, Te Poele R, Williams RD, Wancewicz EV, Monia BP, Workman P, Pritchard-Jones K.

Mol Cancer Ther. 2004 Nov;3(11):1467-84.

19.

Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants.

Chen P, Lepikhova T, Hu Y, Monni O, Hautaniemi S.

Nucleic Acids Res. 2011 Oct;39(18):e123. doi: 10.1093/nar/gkr513. Epub 2011 Jul 10.

20.

Overestimation of alternative splicing caused by variable probe characteristics in exon arrays.

Gaidatzis D, Jacobeit K, Oakeley EJ, Stadler MB.

Nucleic Acids Res. 2009 Sep;37(16):e107. doi: 10.1093/nar/gkp508. Epub 2009 Jun 15.

Items per page

Supplemental Content

Write to the Help Desk